全球體外受精（IVF）市場規模、佔有率、趨勢和成長分析報告（2026-2034）

體外受精（IVF）市場預計將從 2025 年的 325.8 億美元成長到 2034 年的 552.7 億美元，2026 年至 2034 年的複合年成長率為 6.05%。

由於不孕症上升以及人們對輔助生殖技術的認知度提高，全球體外受精（IVF）市場正經歷顯著成長。體外受精（IVF）是指在實驗室中將卵子和精子結合，然後將胚胎移植到子宮內的過程。對於面臨生育挑戰的夫妻來說，這項技術已成為最廣泛使用的不孕症治療方法之一。

生殖醫學和實驗室技術的進步顯著提高了體外受精的成功率。胚胎冷凍、基因篩檢和改良的胚胎培養系統等技術正在改善治療效果。此外，晚育、壓力和環境因素等生活方式的改變也導致全球不孕症治療需求不斷成長。

隨著生育診所不斷採用先進的輔助生殖技術，市場預計將會擴大。在一些地區，政府和醫療機構為生育治療提供財政支持，有助於提高病患的就醫便利性。隨著醫學研究的進步和人們對生育治療方案認知度的提高，全球對體外受精服務的需求將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球體外受精（IVF）市場：依設備分類

• 市場分析、洞察與預測
• 免洗設備
• 培養基
• 裝置

第5章：全球體外受精（IVF）市場：依治療方式分類

• 市場分析、洞察與預測
• 新鮮捐贈者
• 冷凍捐贈者
• 新鮮非捐贈者
• 冷凍非捐贈者

第6章 全球體外受精（IVF）市場：依服務提供者分類

• 市場分析、洞察與預測
• 不孕症治療診所
• 醫院和其他設施

第7章 全球體外受精（IVF）市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Bayer AG
  • Cook Medical LLC
  • EMD Serono Inc.（Merck KGaA）
  • Ferring BV
  • FUJIFILM Irvine Scientific（FUJIFILM Holdings Corporation）
  • Genea Biomedx
  • Merck & Co. Inc
  • The Cooper Companies Inc
  • Thermo Fisher Scientific Inc
  • Vitrolife
  • Boston IVF
  • Nova IVF
  • RMA Network（Reproductive Medicine Associates）

The In Vitro Fertilization Market size is expected to reach USD 55.27 Billion in 2034 from USD 32.58 Billion (2025) growing at a CAGR of 6.05% during 2026-2034.

The global in vitro fertilization market is experiencing strong growth due to rising infertility rates and increasing awareness of assisted reproductive technologies. In vitro fertilization (IVF) involves fertilizing an egg with sperm outside the body in a laboratory before transferring the embryo into the uterus. This procedure has become one of the most widely used fertility treatments for couples experiencing reproductive challenges.

Advancements in reproductive medicine and laboratory technologies are significantly improving IVF success rates. Techniques such as embryo freezing, genetic screening, and improved embryo culture systems are enhancing treatment outcomes. Increasing lifestyle factors such as delayed parenthood, stress, and environmental influences are also contributing to the growing demand for fertility treatments worldwide.

In the future, the market is expected to expand as fertility clinics continue to adopt advanced reproductive technologies. Governments and healthcare organizations in some regions are providing financial support for fertility treatments, increasing accessibility for patients. As medical research progresses and awareness about fertility options grows, the demand for IVF services will continue to rise globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Instrument

• Disposable Devices
• Culture Media
• Equipment

By Procedure Type

• Fresh Donor
• Frozen Donor
• Fresh Non-donor
• Frozen Non-donor

By Providers

• Fertility Clinics
• Hospitals & Others Setting

COMPANIES PROFILED

• Bayer AG, Cook Medical LLC, EMD Serono Inc Merck KGaA, Ferring BV, FUJIFILM Irvine Scientific FUJIFILM Holdings Corporation, Genea Biomedx, Merck Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife, Boston IVF, Nova IVF, RMA Network Reproductive Medicine Associates
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN VITRO FERTILIZATION MARKET: BY INSTRUMENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Instrument
• 4.2. Disposable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Culture Media Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN VITRO FERTILIZATION MARKET: BY PROCEDURE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure Type
• 5.2. Fresh Donor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Frozen Donor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Fresh Non-donor Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Frozen Non-donor Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN VITRO FERTILIZATION MARKET: BY PROVIDERS 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Providers
• 6.2. Fertility Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals & Others Setting Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN VITRO FERTILIZATION MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Instrument
  • 7.2.2 By Procedure Type
  • 7.2.3 By Providers
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Instrument
  • 7.3.2 By Procedure Type
  • 7.3.3 By Providers
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Instrument
  • 7.4.2 By Procedure Type
  • 7.4.3 By Providers
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Instrument
  • 7.5.2 By Procedure Type
  • 7.5.3 By Providers
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Instrument
  • 7.6.2 By Procedure Type
  • 7.6.3 By Providers
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IN VITRO FERTILIZATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Bayer AG
  • 9.2.2 Cook Medical LLC
  • 9.2.3 EMD Serono Inc. (Merck KGaA)
  • 9.2.4 Ferring B.V
  • 9.2.5 FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
  • 9.2.6 Genea Biomedx
  • 9.2.7 Merck & Co. Inc
  • 9.2.8 The Cooper Companies Inc
  • 9.2.9 Thermo Fisher Scientific Inc
  • 9.2.10 Vitrolife
  • 9.2.11 Boston IVF
  • 9.2.12 Nova IVF
  • 9.2.13 RMA Network (Reproductive Medicine Associates)